78 related articles for article (PubMed ID: 3401586)
1. [Heterogeneity of mouse sarcoma cells based on tumorigenicity determined by the different degree of contact inhibition of cell division].
Lavrovskiĭ VA; Ustinov AS
Biull Eksp Biol Med; 1988 Jul; 106(7):88-91. PubMed ID: 3401586
[TBL] [Abstract][Full Text] [Related]
2. Contact reactions influencing cell locomotion of a mouse sarcoma in culture.
Abercrombie M; Turner AA
Med Biol; 1978 Dec; 56(6):299-303. PubMed ID: 366289
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the tumor-growth promoter 12-O-tetradecanoylphorbol-13-acetate on the proliferation of different clones of mouse tumor cells in a semiliquid medium].
Brodskaia RM
Biull Eksp Biol Med; 1986 Apr; 101(4):459-61. PubMed ID: 3697493
[TBL] [Abstract][Full Text] [Related]
4. Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
Chang HL; Gillett N; Figari I; Lopez AR; Palladino MA; Derynck R
Cancer Res; 1993 Sep; 53(18):4391-8. PubMed ID: 8364935
[TBL] [Abstract][Full Text] [Related]
5. Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells.
Chambers AF; Hill RP; Ling V
Cancer Res; 1981 Apr; 41(4):1368-72. PubMed ID: 7214323
[TBL] [Abstract][Full Text] [Related]
6. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
7. Contact inhibition of what? An analytical review.
Martz E; Steinberg MS
J Cell Physiol; 1973 Feb; 81(1):25-37. PubMed ID: 4568376
[No Abstract] [Full Text] [Related]
8. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro.
Roche WR
Am J Pathol; 1985 Apr; 119(1):57-64. PubMed ID: 3985123
[TBL] [Abstract][Full Text] [Related]
9. [Independence from the substrate of multiplication in nonclonal and clonal tumor cell populations].
Brodskaia RM; Stavrovskaia AA
Biull Eksp Biol Med; 1984 Sep; 98(9):342-4. PubMed ID: 6386070
[TBL] [Abstract][Full Text] [Related]
10. Characterization of sarcoma cell lines from v-jun transgenic mice.
Marshall GM; Vanhamme L
Cancer Res; 1993 Feb; 53(3):622-6. PubMed ID: 8425197
[TBL] [Abstract][Full Text] [Related]
11. Tumor progression in nude mice and its representation in cell culture.
Rubin H; Arnstein P; Chu BM
J Natl Cancer Inst; 1986 Nov; 77(5):1125-35. PubMed ID: 3464799
[TBL] [Abstract][Full Text] [Related]
12. Concanavalin A-induced agglutination and tumorigenicity in virally and spontaneously transformed cells derived from BALB-c mice.
Van Nest GA; Grimes WJ
Cancer Res; 1974 Jun; 34(6):1408-12. PubMed ID: 4363657
[No Abstract] [Full Text] [Related]
13. Cell surface adhesiveness of mouse sarcoma lines evaluated by latex particle adherence assay: correlation with growth behavior and electrophoretic mobility.
Bubeník J; Jandlová T; Suhajová E; Malkovský M
Neoplasma; 1979; 26(4):499-501. PubMed ID: 522921
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
15. [Stimulation of grafting of a minimal number of tumor cells after their transplantation into the subcutaneous "air pouch"].
Vasil'ev IuM; Moĭzhess TG
Eksp Onkol; 1985; 7(2):36-7. PubMed ID: 4006847
[TBL] [Abstract][Full Text] [Related]
16. Cellular proliferation in the spleen of DBA/2 mice infected with a myeloproliferative sarcoma virus(MPSV).
Smadja-Joffe F; Le Bousse-Kerdiles MC; Costagliola D; Klein B; Malaise EP; Jasmin C
Exp Hematol; 1981 Feb; 9(2):137-48. PubMed ID: 6263661
[TBL] [Abstract][Full Text] [Related]
17. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
18. [Clonal structure of tumors: difference between clones based on the ability to secrete growth-regulating factors and to react to them].
Stavrovskaia AA; Kishkina VB; Stromskaia TP
Biull Eksp Biol Med; 1986 Aug; 102(8):224-6. PubMed ID: 3742039
[TBL] [Abstract][Full Text] [Related]
19. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
Somers KD; Murphey MM
Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
[TBL] [Abstract][Full Text] [Related]
20. Comparison of surface material, cytoplasmic filaments, and intercellular junctions from untransformed and two mouse sarcoma virus-transformed cell lines.
Dermer GB; Lue J; Neustein HB
Cancer Res; 1974 Jan; 34(1):31-8. PubMed ID: 4358539
[No Abstract] [Full Text] [Related]
[Next] [New Search]
